GE Healthcare, DiaGenic enter research collaboration to develop blood-based test for

[News]

DiaGenic ASA today announced a research agreement to collaborate with GE Healthcare to develop a blood-based test using DiaGenic's peripheral gene expression profiling in patients with mild cognitive impairment, a disorder associated with risk for Alzheimer's Disease.

More... (http://www.news-medical.net/news/20120327/GE-Healthcare-DiaGenic-enter-research-collaboration-to-develop-blood-based-test-for-MCI.aspx)